ID

33157

Beskrivning

Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01449773

Länk

https://clinicaltrials.gov/show/NCT01449773

Nyckelord

Versioner (1)
  1. 2018-11-29 2018-11-29 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

29 november 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes NCT01449773

Engelsk

Eligibility Type 2 Diabetes NCT01449773

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 18 and 55 years,
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
plasma tg levels above the 50th percentile for age,
Beskrivning

Plasma triglyceride measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0583329
non-smoker,
Beskrivning

Non-smoker

Datatyp

boolean

Alias
UMLS CUI [1]
C0337672
bmi between 25.0 and 40.0 kg/m2,
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
stable body weight for at least 6 months prior to the study baseline,
Beskrivning

Stable body weight

Datatyp

boolean

Alias
UMLS CUI [1]
C0517386
hba1c between 6.5 and 8.5%,
Beskrivning

Hemoglobin A1c measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0474680
baseline fasting plasma glucose < 15.0 mmol/l
Beskrivning

Plasma fasting glucose measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0583513
patients with de novo type 2 diabetes not taking oral hypoglycemic agents -- - or patients having received stable doses of metformin for at least 3 months before randomization.
Beskrivning

Non-Insulin-Dependent Diabetes Mellitus de novo | Oral hypoglycemic Absent | Metformin Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C1515568
UMLS CUI [2,1]
C0359086
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
extreme dyslipidemias such as familial hypercholesterolemia,
Beskrivning

Dyslipidemias Extreme | Hypercholesterolemia, Familial

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0242339
UMLS CUI [1,2]
C0205403
UMLS CUI [2]
C0020445
patients with secondary form of diabetes or acute metabolic diabetic complications,
Beskrivning

Secondary diabetes mellitus | Complications of Diabetes Mellitus Metabolic

Datatyp

boolean

Alias
UMLS CUI [1]
C0271640
UMLS CUI [2,1]
C0342257
UMLS CUI [2,2]
C0311400
patients having received or being treated with insulin or a thiazolidinedione within the past 6 months,
Beskrivning

Insulin | Thiazolidinediones

Datatyp

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C1257987
subjects having cvd (chd, cerebrovascular disease or peripheral arterial disease)
Beskrivning

Cardiovascular Disease | Coronary heart disease | Cerebrovascular Disorder | Peripheral Arterial Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0010068
UMLS CUI [3]
C0007820
UMLS CUI [4]
C1704436
subjects taking medications known to affect lipoprotein metabolism (e.g. steroids, beta blockers, thiazide diuretics, lipid lowering agents,
Beskrivning

Pharmaceutical Preparations Affecting Lipoprotein metabolism | Steroids | Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics | Hypolipidemic Agents

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1158917
UMLS CUI [2]
C0038317
UMLS CUI [3]
C0304516
UMLS CUI [4]
C0012802
UMLS CUI [5]
C0086440
significant alcohol intake
Beskrivning

Alcohol consumption Significant

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0750502
Tillbaka till toppen

Similar models

Eligibility Type 2 Diabetes NCT01449773

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age between 18 and 55 years,
boolean
C0001779 (UMLS CUI [1])
Plasma triglyceride measurement
Item
plasma tg levels above the 50th percentile for age,
boolean
C0583329 (UMLS CUI [1])
Non-smoker
Item
non-smoker,
boolean
C0337672 (UMLS CUI [1])
Body mass index
Item
bmi between 25.0 and 40.0 kg/m2,
boolean
C1305855 (UMLS CUI [1])
Stable body weight
Item
stable body weight for at least 6 months prior to the study baseline,
boolean
C0517386 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c between 6.5 and 8.5%,
boolean
C0474680 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
baseline fasting plasma glucose < 15.0 mmol/l
boolean
C0583513 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus de novo | Oral hypoglycemic Absent | Metformin Dose Stable
Item
patients with de novo type 2 diabetes not taking oral hypoglycemic agents -- - or patients having received stable doses of metformin for at least 3 months before randomization.
boolean
C0011860 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C0359086 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Dyslipidemias Extreme | Hypercholesterolemia, Familial
Item
extreme dyslipidemias such as familial hypercholesterolemia,
boolean
C0242339 (UMLS CUI [1,1])
C0205403 (UMLS CUI [1,2])
C0020445 (UMLS CUI [2])
Secondary diabetes mellitus | Complications of Diabetes Mellitus Metabolic
Item
patients with secondary form of diabetes or acute metabolic diabetic complications,
boolean
C0271640 (UMLS CUI [1])
C0342257 (UMLS CUI [2,1])
C0311400 (UMLS CUI [2,2])
Insulin | Thiazolidinediones
Item
patients having received or being treated with insulin or a thiazolidinedione within the past 6 months,
boolean
C0021641 (UMLS CUI [1])
C1257987 (UMLS CUI [2])
Cardiovascular Disease | Coronary heart disease | Cerebrovascular Disorder | Peripheral Arterial Disease
Item
subjects having cvd (chd, cerebrovascular disease or peripheral arterial disease)
boolean
C0007222 (UMLS CUI [1])
C0010068 (UMLS CUI [2])
C0007820 (UMLS CUI [3])
C1704436 (UMLS CUI [4])
Pharmaceutical Preparations Affecting Lipoprotein metabolism | Steroids | Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics | Hypolipidemic Agents
Item
subjects taking medications known to affect lipoprotein metabolism (e.g. steroids, beta blockers, thiazide diuretics, lipid lowering agents,
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1158917 (UMLS CUI [1,3])
C0038317 (UMLS CUI [2])
C0304516 (UMLS CUI [3])
C0012802 (UMLS CUI [4])
C0086440 (UMLS CUI [5])
Alcohol consumption Significant
Item
significant alcohol intake
boolean
C0001948 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial